Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

NCT07459296 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

266

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma (NPC)

Interventions

DRUG: Becotatug Vedotin
DRUG: Sintilimab
DRUG: Cisplatin
RADIATION: intensity-modulated radiotherapy
DRUG: Gemcitabine (GEM)
DRUG: Cisplatin

Sponsor

First Affiliated Hospital of Guangxi Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]